Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 8 | 5 | −3 |
| Shares | 224.9K | 4.50K | −220.4K (−98.0%) |
| Value | $87.5K | $16.9K | −$70.6K (−80.7%) |
New holders (2)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 3,367 | $12.7K | 0.00% |
| Raymond James Financial Inc | 1,000 | $3.77K | 0.00% |
Sold out (5)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 94,916 | $36.9K |
| Armistice Capital, LLC | 70,399 | $27.4K |
| Geode Capital Management, LLC | 33,884 | $13.2K |
| Two Sigma Securities, LLC | 22,189 | $8.63K |
| Barclays PLC | 3 | $1 |